Agenus Inc. rose 5.47% in intraday trading, with the company announcing an update to its virtual Stakeholder Briefing on August 27, 2025. The event will cover strategic and financial overviews, partnership momentum, patient needs in colorectal cancer studies, recent clinical updates, and an overview of the Phase 3 BATTMAN study in metastatic CRC.
Comments
No comments yet